Interstitial Cystitis - Market Insights, Epidemiology and Market Forecast-2023

Publisher Name :
Date: 01-Apr-2017
No. of pages: 73
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Interstitial Cystitis - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Interstitial Cystitis for the seven major markets i.e. United States, Europe (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue, treatment practice and Interstitial Cystitis forecasted market share from 2017 to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Interstitial Cystitis till 2023.

Interstitial cystitis (IC) also known as painful bladder syndrome is a chronic disease that results in recurring discomfort or pain in the bladder and the surrounding pelvic region. This is considered as multiple bladder condition as it can lead to many other problems.

Current studies estimate that 2.7% to 6.5% of women in the United States have symptoms consistent with a diagnosis of interstitial cystitis/bladder pain syndrome (IC/BPS). PBS/IC is more common in women, with a female/male ratio that ranges from 5:1 to 10:1 and the Median age at diagnosis is 42 to 46 yr old whereas men are diagnosed at a younger age.

According to DelveInsight, the Interstitial Cystitis market for 7MM is estimated to be USD 427.2 Million by 2023 at a CAGR of (XX%). The number of Incident Probable IC cases is expected to reach 197,086 cases in 2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

- The report will help in developing business strategies by understanding the trends shaping and driving the global Interstitial Cystitis market.

- Organize sales and marketing efforts by identifying the best opportunities for Interstitial Cystitis in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

- To understand the future market competition in the global Interstitial Cystitis market and Insightful review of the key market drivers and barriers.

- To understand the regulatory scenario in major markets.

- The Report also covers the detailed global historical and forecasted Interstitial Cystitis market covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.

Interstitial Cystitis - Market Insights, Epidemiology and Market Forecast-2023

Table of Contents

Report Introduction
Interstitial Cystitis(IC)/ Bladder Pain Syndrome (BPS) Market Overview at a Glance
Global Market Size of IC/BPS in 2016
Global Market Size of IC/BPS in 2023
Interstitial Cystitis (IC)
Overview
Types
Cause
Pathophysiology
Symptoms
Risk Factor
Diagnosis
Medical devices
United States
Europe
Epidemiology and Patient Population
Assumptions and Caveats
Interstitial Cystitis(IC)/ Bladder Pain Syndrome (BPS) Geography wise Incident Probable IC Cases
7MM Incident Probable IC Cases in 2016
7MM Incident Probable IC Cases in 2023
United States
Incident Probable Cases of Interstitial Cystitis in United States
Europe
Germany
Incident Probable Cases of Interstitial Cystitis in Germany
Italy
Incident Probable Cases of Interstitial Cystitis in Italy
Spain
Incident Probable Cases of Interstitial Cystitis in Spain
France
Incident Probable Cases of Interstitial Cystitis in France
United Kingdom
Incident Probable Cases of Interstitial Cystitis in United Kingdom
Japan
Incident Cases of Interstitial Cystitis in Japan
Treatment Algorithm
United States
First Line Treatment
Second Line Treatment
Third Line Treatment
Fourth Line Treatment
Fifth line treatment
Sixth line treatment
Japan
Europe
Marketed Drugs
List of Marketed Drugs
Elmiron: Janssen Pharmaceutical
Regulatory Milestones
Advantages & Disadvantages
Safety and Efficacy of Elmiron
Side effects of Elmiron
Product Profile
SWOT Analysis of Elmiron
Marketed Medical Devices
RIMSO-50: Mylan Pharmaceutical
Advantages & Disadvantages
Product Profile
Safety and Efficacy of RIMSO-50
Side effects of RIMSO-50
Cystistat: Bioniche Life Sciences Inc
Advantages & Disadvantages
Product Profile
Safety and Efficacy of Cystistat
Side effects of Cystistat
Gepan instill: Pohl-Boskamp GmbH & Co
Advantages & Disadvantages
Product Profile
Safety and Efficacy of Gepan instill
Side effects of Gepan instill
Uracyst: Stellar Pharmaceuticals
Regulatory Milestones
Advantages & Disadvantages
Product Profile
Safety and Efficacy of Uracyst
Side effects of Uracyst
Hyacyst : Syner-Med Ltd
Advantages & Disadvantages
Product Profile
Side effects of Hyacyst
iAluRil: Aspire Pharma
Advantages & Disadvantages
Product Profile
Side effects of iAluRil
Emerging Therapies
Pipeline Drugs
AQX 1125: Aquinox
Regulatory Milestones
Clinical Development
Product Profile
Clinical Pipeline Activity
Ongoing Trials Information
Clinical Trial by Phase
SWOT Analysis
Mirabegron: Astellas Pharma
Clinical Development
Product Profile
Clinical Pipeline Activity
Ongoing Trials Information
Clinical Trial by Phase
SWOT Analysis
Market Size
Global Interstitial Cystitis Market Analysis
Overview of Global Interstitial Cystitis Market (2013-2023)
Total 7MM Interstitial Cystitis Market Analysis
Overview of Total Interstitial Cystitis Market (2013-2023)
Interstitial Cystitis(IC)/ Bladder Pain Syndrome (BPS) Region wise Market Analysis
Region wise Market Size (2016, 2023)
7MM Interstitial Cystitis: Country-Wise Market Analysis
Overview on Total Interstitial Cystitis Market (2016)
Overview on Total Interstitial Cystitis Market (2023)
Global Interstitial Cystitis: Market Analysis
United States Market Size
Europe Market Size
Germany Market Size
France Market Size
United Kingdom Market Size
Spain Market Size
Italy Market Size
Japan Market Size
Market Drivers
Market Barriers
Unmet Needs
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1: Incident Cases of Interstitial Cystitis in United States (2013-2023)
Table 2: Incident Cases of Interstitial Cystitis in Germany (2013-2023)
Table 3: Incident Cases of Interstitial Cystitis in Italy (2013-2023)
Table 4: Incident Cases of Interstitial Cystitis in Spain (2013-2023)
Table 5: Incident Cases of Interstitial Cystitis in France (2013-2023)
Table 6: Incident Cases of Interstitial Cystitis in United Kingdom (2013-2023)
Table 7: Incident Cases of Interstitial Cystitis in Japan (2013-2023)
Table 8: List of Phase III Drugs for Interstitial Cystitis
Table 9: AQX-1125, Clinical Trials by Zone, 2017
Table 10: Clinical Trials by Recruitment status, 2017
Table 11: Mirabegron, Clinical Trials by Zone, 2017
Table 12: Clinical Trials by Recruitment status, 2017
Table 13: Global Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 14: Total 7 Major Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 15: Region wise Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 16: Total Interstitial Cystitis , Distribution share (2016) as per the 7MM
Table 17: Total Interstitial Cystitis , Distribution share (2023) as per the 7MM
Table 18: United States Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 19: Germany Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 20: France Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 21: United Kingdom Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 22: Spain Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 23: Italy Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 24: Japan Market Size of Interstitial Cystitis in USD, Million (2013-2023)



List of Figures

Figure 1: Pathophysiology for Interstitial Cystitis
Figure 2: Risk Factors for Interstitial Cystitis
Figure 4: Incident Probable Cases of Interstitial Cystitis in United States (2013-2023)
Figure 5: Incident Probable Cases of Interstitial Cystitis in Germany (2013-2023)
Figure 6: Incident Probable Cases of Interstitial Cystitis in Italy (2013-2023)
Figure 7: Incident Probable Cases of Interstitial Cystitis in Spain (2013-2023)
Figure 8: Incident Probable Cases of Interstitial Cystitis in France (2013-2023)
Figure 9: Incident Probable Cases of Interstitial Cystitis in United Kingdom (2013-2023)
Figure 10: Incident Probable Cases of Interstitial Cystitis in Japan (2013-2023)
Figure 11: Treatment Algorithm by American Urology association
Figure 12: Lines of Treatment by American Urology Association
Figure 13: AQX-1125, Clinical Trials by Zone (%), 2017
Figure 14: AQX-1125, Clinical Trials by Recruitment status (%), 2017
Figure 15: Mirabegron, Clinical Trials by Zone (%), 2017
Figure 16: Mirabegron, Clinical Trials by Recruitment status (%), 2017
Figure 17: Global Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 18: Total 7 Major Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 19: Region wise Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 20: Total 7 Major Market Size of Interstitial Cystitis in USD, Million (2016)
Figure 21: Total 7 Major Market Size of Interstitial Cystitis in USD, Million (2023)
Figure 22: United States Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 23: Germany Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 24: France Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 25: United Kingdom Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 26: Spain Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 27: Italy Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 28: Japan Market Size of Interstitial Cystitis in USD, Million (2013-2023)






List of Tables


Table 1: Incident Cases of Interstitial Cystitis in United States (2013-2023)
Table 2: Incident Cases of Interstitial Cystitis in Germany (2013-2023)
Table 3: Incident Cases of Interstitial Cystitis in Italy (2013-2023)
Table 4: Incident Cases of Interstitial Cystitis in Spain (2013-2023)
Table 5: Incident Cases of Interstitial Cystitis in France (2013-2023)
Table 6: Incident Cases of Interstitial Cystitis in United Kingdom (2013-2023)
Table 7: Incident Cases of Interstitial Cystitis in Japan (2013-2023)
Table 8: List of Phase III Drugs for Interstitial Cystitis
Table 9: AQX-1125, Clinical Trials by Zone, 2017
Table 10: Clinical Trials by Recruitment status, 2017
Table 11: Mirabegron, Clinical Trials by Zone, 2017
Table 12: Clinical Trials by Recruitment status, 2017
Table 13: Global Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 14: Total 7 Major Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 15: Region wise Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 16: Total Interstitial Cystitis , Distribution share (2016) as per the 7MM
Table 17: Total Interstitial Cystitis , Distribution share (2023) as per the 7MM
Table 18: United States Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 19: Germany Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 20: France Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 21: United Kingdom Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 22: Spain Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 23: Italy Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Table 24: Japan Market Size of Interstitial Cystitis in USD, Million (2013-2023)




List of Figures

Figure 1: Pathophysiology for Interstitial Cystitis
Figure 2: Risk Factors for Interstitial Cystitis
Figure 4: Incident Probable Cases of Interstitial Cystitis in United States (2013-2023)
Figure 5: Incident Probable Cases of Interstitial Cystitis in Germany (2013-2023)
Figure 6: Incident Probable Cases of Interstitial Cystitis in Italy (2013-2023)
Figure 7: Incident Probable Cases of Interstitial Cystitis in Spain (2013-2023)
Figure 8: Incident Probable Cases of Interstitial Cystitis in France (2013-2023)
Figure 9: Incident Probable Cases of Interstitial Cystitis in United Kingdom (2013-2023)
Figure 10: Incident Probable Cases of Interstitial Cystitis in Japan (2013-2023)
Figure 11: Treatment Algorithm by American Urology association
Figure 12: Lines of Treatment by American Urology Association
Figure 13: AQX-1125, Clinical Trials by Zone (%), 2017
Figure 14: AQX-1125, Clinical Trials by Recruitment status (%), 2017
Figure 15: Mirabegron, Clinical Trials by Zone (%), 2017
Figure 16: Mirabegron, Clinical Trials by Recruitment status (%), 2017
Figure 17: Global Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 18: Total 7 Major Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 19: Region wise Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 20: Total 7 Major Market Size of Interstitial Cystitis in USD, Million (2016)
Figure 21: Total 7 Major Market Size of Interstitial Cystitis in USD, Million (2023)
Figure 22: United States Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 23: Germany Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 24: France Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 25: United Kingdom Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 26: Spain Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 27: Italy Market Size of Interstitial Cystitis in USD, Million (2013-2023)
Figure 28: Japan Market Size of Interstitial Cystitis in USD, Million (2013-2023)


  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Overactive Bladder - Pipeline Review, H1 2017
    Published: 09-May-2017        Price: US 2000 Onwards        Pages: 114
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Overactive Bladder - Pipeline Review, H1 2017, provides an overview of the Overactive Bladder (Genito Urinary System And Sex Hormones) pipeline landscape.Overactive bladder is a problem with bladder-storage function that causes a sudden urge to urinate. The urge may be difficult to stop, and overactive bladder may lead to the involuntary loss of urine (incontinence). Symptoms include feel a sudden urge to urin......
  • Interstitial Cystitis - Pipeline Review, H1 2017
    Published: 28-Apr-2017        Price: US 2000 Onwards        Pages: 82
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Interstitial Cystitis - Pipeline Review, H1 2017, provides an overview of the Interstitial Cystitis (Genito Urinary System And Sex Hormones) pipeline landscape. Interstitial cystitis also called painful bladder syndrome is a chronic condition in which person experience bladder pressure, bladder pain and sometimes pelvic pain, ranging from mild discomfort to severe pain. Symptoms include decreased bladd......
  • Urinary Incontinence - Market Insights, Epidemiology and Market Forecast -2023-7MM
    Published: 01-Apr-2017        Price: US 4950 Onwards        Pages: 77
    DelveInsight's "Urinary Incontinence - Market Insights, Epidemiology and Market Forecast-2023-7MM" Reports provides an overview of the disease and global market size of the Urinary Incontinence for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Urinary Incontinence from 2013-2023. Urinary Incontinence is a multifactorial syndrome which occurs due to the failure of the storage......
  • Interstitial Cystitis - Epidemiology Insights -2023
    Published: 01-Apr-2017        Price: US 2750 Onwards        Pages: 51
    DelveInsight's "Interstitial Cystitis - Epidemiology Insights -2023" Reports provides an overview of the disease. The Report includes global forecast of epidemiology of Interstitial Cystitis till 2023. Interstitial cystitis (IC) also known as painful bladder syndrome is a chronic disease that results in recurring discomfort or pain in the bladder and the surrounding pelvic region. This is considered as multiple bladder condition as it can lead to many other problems. Current studies estimate tha......
  • Urinary Incontinence - Epidemiology Forecast To 2023
    Published: 01-Apr-2017        Price: US 2750 Onwards        Pages: 51
    DelveInsight's Urinary Incontinence - Epidemiology Forecast To 2023" Reports provides an overview of the disease and epidemiology trends of the Urinary Incontinence for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Urinary Incontinence from 2013-2023. Urinary Incontinence is a multifactorial syndrome which occurs due to the failure of the storage function of the lower urinary......
  • Pyelonephritis - Pipeline Review, H1 2017
    Published: 31-Mar-2017        Price: US 2000 Onwards        Pages: 58
    Pyelonephritis - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pyelonephritis - Pipeline Review, H1 2017, provides an overview of the Pyelonephritis (Infectious Disease) pipeline landscape. Pyelonephritis is a specific type of urinary tract infection (UTI) that generally begins in urethra or bladder and travels up into kidneys. Signs and symptoms include fever, abdominal pain, freque......
  • Nocturia - Pipeline Review, H1 2017
    Published: 28-Feb-2017        Price: US 2000 Onwards        Pages: 33
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nocturia - Pipeline Review, H1 2017, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape.Nocturia is defined as need to urinate at least twice during the night. This condition becomes more common as people age and occurs in both men and women, sometimes for different reasons. Causes of nocturia include congestive heart failure, edema of lower extremities, sleeping d......
  • Urinary Incontinence - Pipeline Review, H1 2017
    Published: 28-Feb-2017        Price: US 2000 Onwards        Pages: 66
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H1 2017, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape.Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder's contents or it may just cause minor leakage. Symptoms include stress incontinence, rashes and other skin disorders. Risk factors includ......
  • Interstitial Cystitis (Painful Bladder Syndrome)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Jan-2017        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Interstitial Cystitis (Painful Bladder Syndrome)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Interstitial Cystitis (Painful Bladder Syndrome) Report is to understand the market and pipeline status of the drugs around the Interstitial Cystitis (Painful Bladder Syndrome) to explore th......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs